Durabond All Purpose Joint Compound

Product Description

Durabond All Purpose joint compound was a setting-type drywall finishing product manufactured by United States Gypsum (USG), one of the largest and most established gypsum and building materials companies in North America. Unlike conventional drying-type joint compounds that harden through water evaporation, Durabond was formulated as a chemically setting compound, meaning it hardened through a chemical hydration reaction. This characteristic made it particularly valued in commercial and industrial construction applications where faster cure times and greater hardness were required.

The product was marketed and sold broadly during the early 1970s, positioning itself as a versatile compound suitable for embedding joint tape, filling gaps, and finishing gypsum board assemblies in both new construction and renovation work. During the period from approximately 1970 through 1976, the Durabond All Purpose formulation contained chrysotile asbestos as a functional ingredient. USG phased asbestos out of its joint compound products during the mid-1970s, consistent with broader industry reformulations prompted by growing regulatory scrutiny and the emergence of federal asbestos standards.

United States Gypsum has been a defendant in asbestos litigation across multiple jurisdictions, with plaintiffs identifying Durabond All Purpose among the company’s asbestos-containing product lines from this era.

Asbestos Content

Durabond All Purpose joint compound produced between 1970 and 1976 contained chrysotile asbestos. Chrysotile, sometimes referred to as “white asbestos,” is a serpentine-form mineral fiber that was widely incorporated into construction materials throughout the twentieth century due to its flexibility, tensile strength, and compatibility with gypsum and cementitious binders.

In joint compounds, chrysotile asbestos served several functional roles. The fiber structure helped bind the compound matrix, improved workability during application, and reduced cracking during the curing process. In a chemically setting product like Durabond, asbestos fibers also contributed to the durability and dimensional stability of the hardened compound.

The presence of chrysotile in setting-type compounds like Durabond is consistent with documented asbestos use across USG’s product portfolio during this period, as well as with industry-wide practices among joint compound manufacturers in the late 1960s and early 1970s. Litigation records document that plaintiffs identified Durabond All Purpose as an asbestos-containing product based on product testing, historical formulation records, and manufacturer documentation produced during discovery.

How Workers Were Exposed

Workers encountered Durabond All Purpose joint compound across a range of industrial and commercial construction settings during the years the asbestos-containing formulation was on the market. Although the product was used broadly, industrial workers and construction tradespeople involved in drywall installation and finishing were among those with the most frequent and direct contact.

Asbestos fiber release from joint compounds like Durabond occurred primarily during activities that disturbed the dry or partially cured material. Key exposure scenarios included:

Mixing: Durabond, as a setting-type compound, was typically supplied as a dry powder that workers mixed with water on the job site. Pouring and agitating the dry powder generated airborne dust that could contain respirable asbestos fibers. Workers who mixed the compound in enclosed or poorly ventilated areas faced potentially significant fiber concentrations.

Application and Taping: Applying the wet compound to wallboard joints, embedding tape, and feathering edges involved sustained direct contact with the material. While wet compound releases fewer fibers than dry powder, application work often followed or preceded dry sanding stages, creating cumulative exposure.

Sanding and Finishing: Sanding hardened Durabond to achieve smooth, paint-ready surfaces was among the highest-exposure tasks associated with joint compound use. Dry sanding of a set compound generates fine, respirable dust that can remain airborne for extended periods. Hand sanding and mechanical sanding both produced significant dust, and workers in enclosed spaces without respiratory protection could inhale substantial quantities of asbestos-containing particulate.

Cleanup and Debris Handling: Sweeping dried compound residue, handling waste bags of the powder product, and cleaning mixing equipment also created secondary dust exposures. Workers in the vicinity of these activities, including those not directly performing finishing work, could be exposed as bystanders.

Plaintiffs alleged in litigation that United States Gypsum was aware, or should have been aware, of the hazards posed by asbestos-containing dust generated during the use of Durabond and similar products, and that the company failed to provide adequate warnings to workers and end users. Plaintiffs further alleged that the absence of clear hazard communication on product packaging and in technical literature contributed to workers handling the material without respiratory protection.

The latency period for asbestos-related diseases — which can span twenty to fifty years between initial exposure and clinical diagnosis — means that workers who used Durabond All Purpose in the early to mid-1970s may only now be receiving diagnoses of mesothelioma, asbestosis, lung cancer, or other asbestos-related conditions.

Documented Trust Fund / Legal Options

Durabond All Purpose joint compound is a Tier 2 litigated product. There is no established asbestos bankruptcy trust fund associated with United States Gypsum that covers claims arising from Durabond or USG’s other asbestos-containing construction products. USG has not undergone asbestos-driven bankruptcy reorganization of the kind that resulted in trust fund creation for many other asbestos defendants.

As a result, legal remedies for individuals diagnosed with asbestos-related diseases linked to Durabond All Purpose exposure are pursued primarily through direct civil litigation against United States Gypsum Company and, depending on circumstances, against other parties in the chain of distribution, supply, or installation.

Who May Have Legal Claims

Litigation records document that claimants who have pursued legal action related to Durabond and similar USG joint compound products have generally included:

  • Workers who mixed, applied, or sanded Durabond All Purpose in commercial, industrial, or construction settings between 1970 and 1976
  • Workers who performed drywall finishing in facilities where Durabond was present, including those exposed as bystanders to dust generated by others
  • Family members who may allege secondary or take-home exposure from workers who brought asbestos-contaminated clothing and materials into the home

Diagnoses Involved in Litigation

Litigation records document claims associated with asbestos-related diagnoses including:

  • Mesothelioma (pleural, peritoneal, and pericardial)
  • Asbestos-related lung cancer
  • Asbestosis
  • Pleural plaques and pleural thickening

Steps for Affected Workers

Individuals diagnosed with an asbestos-related disease who believe they were exposed to Durabond All Purpose joint compound should consult with an attorney experienced in asbestos litigation. Because statutes of limitations vary by state and typically begin running from the date of diagnosis or the date a claimant reasonably should have known of the asbestos connection, prompt legal consultation is important. An attorney can review employment history, product identification records, co-worker testimony, and medical documentation to evaluate the viability of a claim against United States Gypsum and any other potentially responsible parties.